Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125835302 | 12583530 | 2 | F | 201606 | 20160713 | 20160722 | 20160726 | EXP | GB-JNJFOC-20160710525 | JANSSEN | 29.86 | YR | A | M | Y | 69.00000 | KG | 20160726 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125835302 | 12583530 | 1 | SS | DARUNAVIR | DARUNAVIR | 1 | Oral | N | 0 | 800 | MG | TABLETS | QD | ||||||
| 125835302 | 12583530 | 2 | PS | DARUNAVIR | DARUNAVIR | 1 | Oral | N | 21976 | TABLETS | |||||||||
| 125835302 | 12583530 | 3 | SS | REZOLSTA | COBICISTATDARUNAVIR ETHANOLATE | 1 | Oral | Y | N | 205395 | 1 | DF | TABLET | ||||||
| 125835302 | 12583530 | 4 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 125835302 | 12583530 | 5 | SS | COBICISTAT | COBICISTAT | 1 | Oral | 0 | 150 | MG | TABLET | QD | |||||||
| 125835302 | 12583530 | 6 | SS | COBICISTAT | COBICISTAT | 1 | Oral | 0 | TABLET | ||||||||||
| 125835302 | 12583530 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125835302 | 12583530 | 8 | C | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125835302 | 12583530 | 9 | C | COLPERMIN | 2 | Unknown | 0 | UNSPECIFIED | |||||||||||
| 125835302 | 12583530 | 10 | C | CANNABIS | CANNABIS SATIVA SUBSP. INDICA TOP | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125835302 | 12583530 | 1 | HIV infection |
| 125835302 | 12583530 | 2 | HIV infection |
| 125835302 | 12583530 | 3 | HIV infection |
| 125835302 | 12583530 | 4 | HIV infection |
| 125835302 | 12583530 | 5 | HIV infection |
| 125835302 | 12583530 | 6 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125835302 | 12583530 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125835302 | 12583530 | Abnormal weight gain | |
| 125835302 | 12583530 | Blood creatinine increased | |
| 125835302 | 12583530 | Glomerular filtration rate decreased | |
| 125835302 | 12583530 | Headache | |
| 125835302 | 12583530 | Lethargy | |
| 125835302 | 12583530 | Muscle mass |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125835302 | 12583530 | 1 | 201605 | 0 | ||
| 125835302 | 12583530 | 3 | 201606 | 201606 | 0 | |
| 125835302 | 12583530 | 4 | 20141013 | 0 | ||
| 125835302 | 12583530 | 5 | 201603 | 201605 | 0 |